Trial Profile
Safety and Efficacy of 5-aminolevulinic acid hydrochloride (5-ALA-HCl) and Sodium Ferrous Citrate (SFC) in patients with uncomplicated plasmodium falciparum malaria
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 12 Nov 2019
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid/sodium ferrous citrate (Primary) ; Artemether/lumefantrine
- Indications Falciparum malaria
- Focus Adverse reactions; Therapeutic Use
- Sponsors NeoPharma
- 12 Nov 2018 New trial record